Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1810880

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1810880

Diabetes Treatment Devices Global Market Report 2025

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 4490
PDF (Site License)
USD 6490
PDF (Enterprise License)
USD 8490

Add to Cart

Diabetes treatment devices are specialized medical tools designed to help individuals manage and treat diabetes by monitoring blood sugar levels, administering insulin, or addressing related health concerns. These devices play a crucial role in helping patients achieve optimal blood glucose control and prevent complications linked to diabetes.

The primary types of diabetes treatment devices include blood glucose monitoring devices, self-monitoring tools, blood glucose meters, testing strips, lancets, continuous glucose monitoring devices, sensors, transmitters, receivers, and other related equipment. Blood glucose monitoring devices are essential for measuring blood sugar levels, assisting individuals in effectively managing their diabetes. These devices are available through various distribution channels, including hospital pharmacies, retail pharmacies, diabetes clinics, institutional sales, and online pharmacies. They cater to a wide range of users, such as hospitals, homecare settings, diagnostic centers, ambulatory surgery centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The diabetes treatment devices market research report is one of a series of new reports from The Business Research Company that provides diabetes treatment devices market statistics, including diabetes treatment devices industry global market size, regional shares, competitors with a diabetes treatment devices market share, detailed diabetes treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes treatment devices industry. The diabetes treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diabetes treatment devices market size has grown strongly in recent years. It will grow from $11.61 billion in 2024 to $12.34 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth during the historic period can be attributed to several key factors, including the rising prevalence of diabetes, greater awareness about effective diabetes management, a growing adoption of insulin delivery devices, increased healthcare expenditure in developing countries, and the expanding availability of advanced glucose monitoring systems.

The diabetes treatment devices market size is expected to see strong growth in the next few years. It will grow to $15.61 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth projected for the forecast period can be attributed to several factors, including a rising demand for wearable and non-invasive monitoring devices, an increasing focus on personalized diabetes care, greater adoption of digital health platforms and apps, a growing need for remote diabetes management solutions, and expanding government initiatives supporting diabetes control programs. Key trends to watch during this period include advancements in continuous glucose monitoring technology, the development of advanced insulin delivery systems integrated with artificial intelligence, the rise of smart wearable diabetes devices, innovations in non-invasive blood sugar monitoring, and the integration of voice assistants into device operations.

The rising obesity rates are anticipated to accelerate the growth of the diabetes treatment devices market due to the increasing demand for solutions to manage diabetes. Obesity is determined by the percentage of individuals with a body mass index (BMI) classified as obese. The surge in obesity is mainly driven by poor dietary habits rich in calories, sugars, and fats, leading to excessive weight gain when not counterbalanced with physical activity. Diabetes treatment devices help manage blood sugar levels, which in turn promotes healthier lifestyle choices and assists in weight management. For instance, in September 2023, the Centers for Disease Control and Prevention (CDC) reported that, in 2022, 22 U.S. states had an adult obesity rate of 35% or higher, an increase from 19 states in 2021. As a result, the growing obesity rates are propelling the diabetes treatment devices market.

Leading companies in the diabetes treatment devices market are focusing on developing cutting-edge solutions like hybrid closed-loop insulin pump systems to enhance glycemic control and alleviate the burden of diabetes management for patients. A hybrid closed-loop insulin pump system is an advanced device that adjusts insulin delivery automatically based on readings from continuous glucose monitors (CGMs) while requiring users to manually input mealtime insulin doses. For instance, in March 2022, Medtronic PLC introduced the MiniMed 780G system with SmartGuard technology for managing type 1 diabetes in individuals aged 7 to 80 years. This system automatically adjusts basal insulin levels and provides correction boluses every five minutes to maintain glucose levels within a personalized target range, even compensating for missed meal boluses or incorrect carbohydrate estimates. The system also features Meal Detection technology, a CGM that eliminates the need for fingersticks, and an infusion set that lasts up to seven days, all of which can be controlled via a mobile app.

In September 2023, Abbott Laboratories, a US-based medical device company, acquired Bigfoot Biomedical for an undisclosed sum. This acquisition enables Abbott Laboratories to combine continuous glucose monitoring with smart insulin dosing technology, aiming to deliver more personalized, connected, and accessible diabetes care. Bigfoot Biomedical Inc. is a US-based medical technology company that specializes in developing and providing diabetes treatment devices.

Major players in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Eli Lilly And Company, Novo Nordisk A/S, Becton, Dickinson And Company, Hoffmann-La Roche Ltd., Insulet Corporation, DexCom Inc., Tandem Diabetes Care Inc, Lifescan Inc., Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc., Bigfoot Biomedical Inc., Medtrum Technologies Inc., Diabeloop SA, Roche Diabetes Care GmbH.

North America was the largest region in the diabetes treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diabetes treatment devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diabetes treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diabetes treatment devices market consists of sales of smart insulin pens, artificial pancreas systems, closed-loop systems, and jet injectors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diabetes Treatment Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetes treatment devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diabetes treatment devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diabetes treatment devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Blood Glucose Monitoring Devices; Self-Monitoring Devices; Blood Glucose Meters; Testing Strips; Lancets; Continuous Glucose Monitoring Devices; Sensors; Transmitters; Receiver; Other Device Types
  • 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Diabetes Clinics Or Centers; Institutional Sales; Online Pharmacies; Other Distribution Channels
  • 3) By End-User: Hospitals; Homecare; Diagnostic Centers; Ambulatory Surgery Centers; Other End-Users
  • Subsegments:
  • 1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices; Non-Invasive Blood Glucose Monitoring Devices
  • 2) By Self-Monitoring Devices: Handheld Glucometers; Wearable Self-Monitoring Devices
  • 3) By Blood Glucose Meters: Standard Glucose Meters; Smart Or Connected Glucose Meters
  • 4) By Testing Strips: Glucose Oxidase Strips; Glucose Dehydrogenase Strips
  • 5) By Lancets: Standard Lancets; Safety Lancets
  • 6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices; Intermittently Scanned Continuous Glucose Monitoring Devices
  • 7) By Sensors: Short-Term Sensors; Long-Term Implantable Sensors
  • 8) By Transmitters: Reusable Transmitters; Disposable Transmitters
  • 9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors; Smartphone Or Smartwatch-Connected Receivers
  • 10) By Other Device Types: Insulin Pens; Insulin Pumps; Smart Insulin Patches
  • Companies Mentioned: Johnson And Johnson; Abbott Laboratories; Medtronic plc; Eli Lilly And Company; Novo Nordisk A/S; Becton, Dickinson And Company; Hoffmann-La Roche Ltd.; Insulet Corporation; DexCom Inc.; Tandem Diabetes Care Inc; Lifescan Inc.; Ypsomed Holding AG; Ascensia Diabetes Care Holdings AG; B. Braun Melsungen AG; Beta Bionics Inc; Senseonics Holdings Inc.; Bigfoot Biomedical Inc.; Medtrum Technologies Inc.; Diabeloop SA; Roche Diabetes Care GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.
Product Code: r36979

Table of Contents

1. Executive Summary

2. Diabetes Treatment Devices Market Characteristics

3. Diabetes Treatment Devices Market Trends And Strategies

4. Diabetes Treatment Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Diabetes Treatment Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Diabetes Treatment Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Diabetes Treatment Devices Market Growth Rate Analysis
  • 5.4. Global Diabetes Treatment Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Diabetes Treatment Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Diabetes Treatment Devices Total Addressable Market (TAM)

6. Diabetes Treatment Devices Market Segmentation

  • 6.1. Global Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Monitoring Devices
  • Self-Monitoring Devices
  • Blood Glucose Meters
  • Testing Strips
  • Lancets
  • Continuous Glucose Monitoring Devices
  • Sensors
  • Transmitters
  • Receiver
  • Other Device Types
  • 6.2. Global Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Diabetes Clinics Or Centers
  • Institutional Sales
  • Online Pharmacies
  • Other Distribution Channels
  • 6.3. Global Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Homecare
  • Diagnostic Centers
  • Ambulatory Surgery Centers
  • Other Endusers
  • 6.4. Global Diabetes Treatment Devices Market, Sub-Segmentation Of Blood Glucose Monitoring Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Invasive Blood Glucose Monitoring Devices
  • Non-Invasive Blood Glucose Monitoring Devices
  • 6.5. Global Diabetes Treatment Devices Market, Sub-Segmentation Of Self-Monitoring Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Handheld Glucometers
  • Wearable Self-Monitoring Devices
  • 6.6. Global Diabetes Treatment Devices Market, Sub-Segmentation Of Blood Glucose Meters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Glucose Meters
  • Smart Or Connected Glucose Meters
  • 6.7. Global Diabetes Treatment Devices Market, Sub-Segmentation Of Testing Strips, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glucose Oxidase Strips
  • Glucose Dehydrogenase Strips
  • 6.8. Global Diabetes Treatment Devices Market, Sub-Segmentation Of Lancets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Lancets
  • Safety Lancets
  • 6.9. Global Diabetes Treatment Devices Market, Sub-Segmentation Of Continuous Glucose Monitoring Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Real-Time Continuous Glucose Monitoring Devices
  • Intermittently Scanned Continuous Glucose Monitoring Devices
  • 6.10. Global Diabetes Treatment Devices Market, Sub-Segmentation Of Sensors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Short-Term Sensors
  • Long-Term Implantable Sensors
  • 6.11. Global Diabetes Treatment Devices Market, Sub-Segmentation Of Transmitters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reusable Transmitters
  • Disposable Transmitters
  • 6.12. Global Diabetes Treatment Devices Market, Sub-Segmentation Of Receiver, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dedicated Continuous Glucose Monitoring Devices Monitors
  • Smartphone Or Smartwatch-Connected Receivers
  • 6.13. Global Diabetes Treatment Devices Market, Sub-Segmentation Of Other Device Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Pens
  • Insulin Pumps
  • Smart Insulin Patches

7. Diabetes Treatment Devices Market Regional And Country Analysis

  • 7.1. Global Diabetes Treatment Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Diabetes Treatment Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diabetes Treatment Devices Market

  • 8.1. Asia-Pacific Diabetes Treatment Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diabetes Treatment Devices Market

  • 9.1. China Diabetes Treatment Devices Market Overview
  • 9.2. China Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diabetes Treatment Devices Market

  • 10.1. India Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diabetes Treatment Devices Market

  • 11.1. Japan Diabetes Treatment Devices Market Overview
  • 11.2. Japan Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diabetes Treatment Devices Market

  • 12.1. Australia Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diabetes Treatment Devices Market

  • 13.1. Indonesia Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diabetes Treatment Devices Market

  • 14.1. South Korea Diabetes Treatment Devices Market Overview
  • 14.2. South Korea Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diabetes Treatment Devices Market

  • 15.1. Western Europe Diabetes Treatment Devices Market Overview
  • 15.2. Western Europe Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diabetes Treatment Devices Market

  • 16.1. UK Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diabetes Treatment Devices Market

  • 17.1. Germany Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diabetes Treatment Devices Market

  • 18.1. France Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diabetes Treatment Devices Market

  • 19.1. Italy Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diabetes Treatment Devices Market

  • 20.1. Spain Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diabetes Treatment Devices Market

  • 21.1. Eastern Europe Diabetes Treatment Devices Market Overview
  • 21.2. Eastern Europe Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diabetes Treatment Devices Market

  • 22.1. Russia Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diabetes Treatment Devices Market

  • 23.1. North America Diabetes Treatment Devices Market Overview
  • 23.2. North America Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diabetes Treatment Devices Market

  • 24.1. USA Diabetes Treatment Devices Market Overview
  • 24.2. USA Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diabetes Treatment Devices Market

  • 25.1. Canada Diabetes Treatment Devices Market Overview
  • 25.2. Canada Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diabetes Treatment Devices Market

  • 26.1. South America Diabetes Treatment Devices Market Overview
  • 26.2. South America Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diabetes Treatment Devices Market

  • 27.1. Brazil Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diabetes Treatment Devices Market

  • 28.1. Middle East Diabetes Treatment Devices Market Overview
  • 28.2. Middle East Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diabetes Treatment Devices Market

  • 29.1. Africa Diabetes Treatment Devices Market Overview
  • 29.2. Africa Diabetes Treatment Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Diabetes Treatment Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Diabetes Treatment Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diabetes Treatment Devices Market Competitive Landscape And Company Profiles

  • 30.1. Diabetes Treatment Devices Market Competitive Landscape
  • 30.2. Diabetes Treatment Devices Market Company Profiles
    • 30.2.1. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Eli Lilly And Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

31. Diabetes Treatment Devices Market Other Major And Innovative Companies

  • 31.1. Becton, Dickinson And Company
  • 31.2. Hoffmann-La Roche Ltd.
  • 31.3. Insulet Corporation
  • 31.4. DexCom Inc.
  • 31.5. Tandem Diabetes Care Inc
  • 31.6. Lifescan Inc.
  • 31.7. Ypsomed Holding AG
  • 31.8. Ascensia Diabetes Care Holdings AG
  • 31.9. B. Braun Melsungen AG
  • 31.10. Beta Bionics Inc
  • 31.11. Senseonics Holdings Inc.
  • 31.12. Bigfoot Biomedical Inc.
  • 31.13. Medtrum Technologies Inc.
  • 31.14. Diabeloop SA
  • 31.15. Roche Diabetes Care GmbH

32. Global Diabetes Treatment Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diabetes Treatment Devices Market

34. Recent Developments In The Diabetes Treatment Devices Market

35. Diabetes Treatment Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Diabetes Treatment Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Diabetes Treatment Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Diabetes Treatment Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!